Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce a National Cannabis Product Line Psychedelics Investing
Seelos Therapeutics Raises $10 Million In Private Placement of Senior Secured Convertible Note Psychedelics Investing
Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors Cannabis Investing News
MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy Psychedelics Investing
Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme Cannabis Investing News
MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m Psychedelics Investing
Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics Psychedelics Investing
Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Final $40 Million Revenue Milestone Psychedelics Investing
Hollister Biosciences Inc. Wholly Owned subsidiary Hollister Cannabis Co Receives Trademark Approval for Brand HashBone Psychedelics Investing
Seelos Therapeutics to Participate in the 10th Annual LifeSci Partners Corporate Access Event Psychedelics Investing
